CLINICAL EVIDENCE • PATIENT SELECTION • IMPLANT PRACTICE


CHAIRS

BRADLEY P. KNIGHT, MD • LARRY A. CHINITZ, MD • THOMAS F. DEERING, MD

MICHAEL R. GOLD, MD, PHD

The role of autonomic modulation for the treatment of heart failure and the BAROSTIM NEO system mechanism of action.

MARWAN M. BAHU, MD FHRS

BAROSTIM NEO Device Implantation Experience

KHALED A. AWAD, MD, MUSC

Heart failure device treatment algorithm and BAROSTIM NEO patient selection

LUANDA GRAZETTE, MD, MPH

Barostim Therapy Clinical Evidence